Total Payments
$914.37
2021 Payments
$102.54
Companies
11
Transactions
71
Medicare Patients
724
Medicare Billing
$103,777
Payment Breakdown by Category
Food & Beverage$914.37 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $914.37 | 71 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $427.30 | 49 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $108.26 | 7 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $65.19 | 3 | $0 (2021) |
| Respiratory Technologies, Inc. | $43.09 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $37.45 | 2 | $0 (2020) |
| Daiichi Sankyo Inc. | $29.09 | 2 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $28.04 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $23.12 | 2 | $0 (2018) |
| Amgen Inc. | $16.98 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $102.54 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($48.90) |
| 2020 | $105.18 | 7 | Novo Nordisk Inc ($39.71) |
| 2019 | $185.94 | 5 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2018 | $298.04 | 34 | Novo Nordisk Inc ($200.08) |
| 2017 | $222.67 | 19 | Novo Nordisk Inc ($150.87) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Diabetes | ||||||
| 04/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: RESPIRATORY | ||||||
| 03/29/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Diabetes | ||||||
| 02/25/2021 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 02/04/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Diabetes | ||||||
| 11/03/2020 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Respiratory | ||||||
| 10/22/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Diabetes | ||||||
| 06/01/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Diabetes | ||||||
| 03/09/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: RESPIRATORY | ||||||
| 03/04/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Diabetes | ||||||
| 01/08/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Bone Health | ||||||
| 10/24/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 05/20/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: DIABETES | ||||||
| 04/30/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: DIABETES | ||||||
| 03/18/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: DIABETES | ||||||
| 12/13/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Diabetes | ||||||
| 12/13/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $4.41 | General |
| Category: Diabetes | ||||||
| 12/03/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Diabetes | ||||||
| 12/03/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: Diabetes | ||||||
| 11/01/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: Diabetes | ||||||
| 11/01/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Diabetes | ||||||
| 10/05/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 20 | 26 | $9,360 | $2,402 |
| 2021 | 1 | 32 | 39 | $11,310 | $4,639 |
| 2020 | 7 | 672 | 1,238 | $471,335 | $96,737 |
Total Patients
724
Total Services
1,303
Medicare Billing
$103,777
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 20 | 26 | $9,360 | $2,402 | 25.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 32 | 39 | $11,310 | $4,639 | 41.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 147 | 335 | $152,400 | $32,261 | 21.2% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 117 | 232 | $94,460 | $22,518 | 23.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 184 | 373 | $131,760 | $22,083 | 16.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 126 | 180 | $64,800 | $14,235 | 22.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 29 | 29 | $19,380 | $3,844 | 19.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 33 | $7,275 | $1,616 | 22.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 40 | 56 | $1,260 | $179.76 | 14.3% |
About Dr. Michael Gray, M.D
Dr. Michael Gray, M.D is a Internal Medicine healthcare provider based in Benson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639120520.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Gray, M.D has received a total of $914.37 in payments from pharmaceutical and medical device companies, with $102.54 received in 2021. These payments were reported across 71 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($914.37).
As a Medicare-enrolled provider, Gray has provided services to 724 Medicare beneficiaries, totaling 1,303 services with total Medicare billing of $103,777. Data is available for 3 years (2020–2022), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Benson, AZ
- Active Since 05/15/2006
- Last Updated 06/18/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1639120520
Products in Payments
- Victoza (Drug) $250.48
- FASENRA (Drug) $125.00
- TOUJEO (Drug) $94.75
- Ozempic (Drug) $90.94
- STIOLTO RESPIMAT (Drug) $48.90
- Movantik (Drug) $29.09
- LONHALA MAGNAIR (Drug) $28.04
- TRELEGY ELLIPTA (Drug) $24.29
- XARELTO (Drug) $23.12
- EVENITY (Biological) $16.98
- STIOLTO (Drug) $16.29
- SOLIQUA (Drug) $13.51
- ANORO ELLIPTA (Drug) $13.16
- Tresiba (Drug) $12.44
- XIFAXAN (Drug) $10.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Benson
Dr. Viswanatha Reddy, M.d, M.D
Internal Medicine — Payments: $15,688
Internal Medicine $15,688
Dr. Pankaj Vyas, M.d, M.D
Internal Medicine — Payments: $14,825
Internal Medicine $14,825
Dr. Cassandra Harrison, M.d, M.D
Internal Medicine — Payments: $116.04
Internal Medicine $116.04
Dr. Glenn Robertson, Md, MD
Internal Medicine — Payments: $96.76
Internal Medicine $96.76
Dr. Karen Dorn, Md, MD
Internal Medicine
Internal Medicine
Craig Ottenstein, Md, MD
Internal Medicine
Internal Medicine